by jlohrconsulting | Oct 6, 2025 | Uncategorized
J Clin Exp Neuropsychol. 2025 Oct 5:1-9. doi: 10.1080/13803395.2025.2568520. Online ahead of print. ABSTRACT INTRODUCTION: Rumination is a risk factor for the development of depression among adolescents. However, not all at-risk youth develop depression, suggesting...
by jlohrconsulting | Oct 6, 2025 | Uncategorized
Chin Med. 2025 Oct 6;20(1):162. doi: 10.1186/s13020-025-01219-6. ABSTRACT BACKGROUND: Sihosogansan (SHSGS) is a traditional medicine used to treat depression. However, conventional oral administration requires high doses and prolonged treatment periods. This study...
by jlohrconsulting | Oct 6, 2025 | Uncategorized
BMC Public Health. 2025 Oct 6;25(1):3311. doi: 10.1186/s12889-025-24629-5. ABSTRACT BACKGROUND: Improving the mental health and digital divide issues is crucial for promoting active aging. This study aimed to examine the bidirectional relationship and intricate...
by jlohrconsulting | Oct 5, 2025 | Uncategorized
Ann Clin Transl Neurol. 2025 Oct 5. doi: 10.1002/acn3.70199. Online ahead of print. ABSTRACT OBJECTIVE: Cognitive impairment, fatigue, and depression are common in multiple sclerosis (MS), potentially due to disruption of regional functional connectivity caused by...
by jlohrconsulting | Oct 5, 2025 | Uncategorized
Behav Sleep Med. 2025 Oct 5:1-14. doi: 10.1080/15402002.2025.2569364. Online ahead of print. ABSTRACT OBJECTIVES: Cognitive behavioral therapy for insomnia (CBT-I) is the recommended first-line treatment for insomnia. However, patients with objective short sleep...
by jlohrconsulting | Oct 5, 2025 | Uncategorized
Braz J Psychiatry. 2025 Oct 5. doi: 10.47626/1516-4446-2025-4529. Online ahead of print. NO ABSTRACT PMID:41046552 | DOI:10.47626/1516-4446-2025-4529
Recent Comments